Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: a retrospective analysisResearch in context

• Main Authors: Adriana M. Ivama-Brummell (Author), Fernanda L. Marciniuk (Author), Anita K. Wagner (Author), Claudia G.S. Osorio- (Author), Sabine Vogler (Author), Elias Mossialos (Author), Carla L. Tavares- (Author), Huseyin Naci (Author)
• Format: Book
• Published: Elsevier, 2023-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: Most cancer drugs enter the US market first. US Food and Drug Administration (FDA) approvals of new cancer drugs may influence regulatory decisions in other settings. The study examined whether characteristics of available evidence at FDA approval influenced time-to-marketing au...